In a groundbreaking initiative supported by Breakthrough Cancer Research and 5ForTheFight, Trinity College Dublin‘s School of Medicine is offering a unique opportunity for a highly motivated individual to embark on a transformative journey in cancer immunology.
This 3-year PhD position, supervised by Dr. Melissa Conroy and Professor Joanne Lysaght, promises an exciting exploration into the realm of developing “tumor-homing NK cell therapies for obesity-associated cancer.”
Project Overview: Cancer Immunology Research
The focus of this cutting-edge research is to address the urgent need for a novel treatment targeting the poor prognosis and obesity-associated malignancy, oesophageal adenocarcinoma (OAC).
The PhD candidate will leverage in vitro and in vivo pre-clinical models to evaluate the efficacy of innovative immunotherapeutic approaches specifically tailored for OAC.
Qualifications and Skills
Prospective applicants should possess an undergraduate degree or MSc in biomedical sciences, immunology, oncology, or a related discipline.
The ideal candidate will exhibit a profound passion for cancer research and immunology. While experience in cell and tissue culture techniques, flow cytometry, and ELISA is desirable, candidates without in vivo model experience are still encouraged to apply.
Teamwork is pivotal, and applicants must showcase a demonstrated ability to work effectively within a large multidisciplinary team. High levels of initiative, organizational skills, and strong written and oral communication skills are essential.
Application Details
Interested individuals are invited to submit their applications to Dr. Melissa Conroy ([email protected]), School of Medicine, Trinity College Dublin. The application package should include a 1-page Cover Letter outlining the candidate’s interest and experience in cancer research and/or immunology. Additionally, a concise 2-page Curriculum Vitae (not exceeding 2 pages) and the names and contact details of 2 referees should be included.
Important Dates
- Applications Closing Date: 31st January 2024
- Interviews: February 2024 via Zoom
- Starting Date: March 2024
Seize this opportunity to be part of a transformative research journey, contributing to the advancement of cancer immunology and making a real impact on the future of cancer treatments. Apply now and be a pioneer in the fight against obesity-associated cancer.
